The 36-Patient Acne Laser Pilot Published in 2026: Study Design and Evidence Limits for Adults With Persistent Acne

The 36-patient acne laser pilot published in 2026 was a three-arm randomized pilot for moderate-to-severe inflammatory acne, meaning red, swollen pimples and pustules. It compared pulsed dye laser, intense pulsed light, and Q-switched Nd:YAG 1064-nm laser head to head. Lesion counts and disability scores fell during treatment, but the devices did not differ from each other. With about 12 patients per arm and short follow-up, the pilot cannot prove which device works best, how long results last, or who else will benefit.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Who was studied and what was compared
What improved and what did not
Which treatment hurt less?
Why a small pilot cannot pick a winner
What to do if acne persists

Who was studied and what was compared

The U.S. National Library of Medicine PubMed record describes enrollment of 36 patients with moderate-to-severe inflammatory acne across three treatment arms PubMed trial record.

The studied population is adults and older adolescents with persistent inflammatory acne, the group most often offered non-drug laser options. Each arm received a different light-based treatment: pulsed dye laser, intense pulsed light, or Q-switched Nd:YAG 1064-nm laser. The trial aimed to compare both clearing and side effects over repeated sessions and short follow-up.

What improved and what did not

The same PubMed record reports that lesion counts and severity scores fell significantly within each treatment arm over the study PubMed trial results. Yet no significant between-group differences were found at any session, with P values ranging from 0.06 to 0.92.

Acne-related disability also decreased from baseline to two weeks after the final treatment across groups, measured by the Cardiff Acne Disability Index. For readers, that means daily bother eased during care, but the result does not favor one device.

Which treatment hurt less?

The trial aimed to compare both efficacy and side effects. Secondary reporting from BiologyInsights notes less treatment pain with Q-switched Nd:YAG than with intense pulsed light or pulsed dye laser BiologyInsights trial summary.

Pain matters because acne lasers require repeated passes over tender, inflamed skin. A less painful session can make completing a course easier, even when clearing looks similar.

Why a small pilot cannot pick a winner

A Blue Cross/ITI policy summary of acne laser evidence highlights the core limit: small samples and short follow-up. About 12 patients per arm leaves little power to detect real differences, track relapse, or test darker skin types or mainly comedonal acne with blackheads and whiteheads.

The American Academy of Dermatology's 2024 acne guideline found evidence insufficient to recommend laser and light devices routinely and gave no broad recommendation for them AAD guideline news. That stance fits this pilot: encouraging within-group change, but no proof of superiority or durability.

What to do if acne persists

The practical message from the FDA clearance history for acne lasers is to treat these devices as possible add-ons, not replacements for proven topical and systemic care. Adults with persistent acne should keep first-line treatment going unless a dermatologist advises a change. Ask direct questions before booking:.

What diagnosis and acne type do I have, and am I like the patients studied?
How many sessions, what cost, what eye protection, and what aftercare do you use?
How will we measure clearing, pain, side effects, and recurrence?